Vitalhub (TSE:VHI) Given a C$13.50 Price Target at Raymond James

Vitalhub (TSE:VHI) received a C$13.50 price target from Raymond James in a research note issued to investors on Thursday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Raymond James’ target price would suggest a potential upside of 31.84% from the stock’s current price.

VHI has been the subject of a number of other research reports. Canaccord Genuity Group upped their price target on Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research report on Thursday, January 16th. Scotiabank set a C$14.00 target price on Vitalhub and gave the company an “outperform” rating in a report on Thursday, January 30th. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of C$11.92.

Vitalhub Trading Up 6.0 %

VHI stock opened at C$10.24 on Thursday. The stock has a market capitalization of C$553.91 million, a price-to-earnings ratio of 166.55, a PEG ratio of 1.18 and a beta of 1.26. The firm’s 50-day moving average price is C$10.48 and its two-hundred day moving average price is C$10.32. Vitalhub has a 12-month low of C$5.80 and a 12-month high of C$12.09.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.